Beyond fielding an ever-increasing number of digital health clearances, the FDA had a full plate in 2017 as it sought to revise its regulatory processes for the shifting healthcare landscape. The beginning of the year saw a new administration take the reins, and with it the nomination and appointment of a new commissioner, Dr. Scott Gottlieb.
from MobiHealthNews http://ift.tt/2DzeCzc
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment